Educational guide
Cystic Fibrosis-Related Diabetes Associated With Race/Ethnicity - Endocrinology Advisor
Black race and Hispanic ethnicity are associated with higher incidence and prevalence of cystic fibrosis-related diabetes (CFRD), according to study findings published in the Journal of Cystic Fibrosis. Investigators explored whether Black race and Hispanic et
This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.
Black race and Hispanic ethnicity are associated with higher incidence and prevalence of cystic fibrosis-related diabetes (CFRD), according to study findings published in the Journal of Cystic Fibrosis.
Investigators explored whether Black race and Hispanic ethnicity were associated with higher prevalence and incidence of CFRD.
In this retrospective cohort study, investigators used data from the CF Foundation Patient Registry from 2010 to 2019 to determine the prevalence and incidence of CFRD by race/ethnicity. Data were stratified by age at baseline in 2010 into 3 cohorts (11-20 years [y]; 21-30y; 31-40y). Logistic regression was used to determine prevalence and Cox regression was used to determine incidence following adjustments for clinical factors, demographics, socioeconomic status, and chronic medication use. The study did not include persons over 40 years of age due to the fewer number of eligible participants in this age category. Notably, in 2010, median life expectancy for persons with CF was 37 years.
Registry participants (N=14,660) included 510 non-Hispanic Black (NHB) patients and 890 Hispanic patients. Age cohorts were slightly uneven with respect to sex, with progressively fewer women in the older age cohorts (48.0% women in the 11-20y cohort; 46.8% in the 21-30y cohort; and 46.6% in the 31-40y cohort).
In all age cohorts, the investigators found that being a NHB vs a NH White patient was associated with higher odds of CFRD baseline prevalence (11-20y OR, 2.53; 95% CI, 1.88-3.41; 21-30y OR, 1.80; 95% CI, 1.25-2.59; 31-40y OR, 1.93; 95% CI, 1.00-3.73; P <.005 for all). In the youngest age cohort, there was a 40% higher risk for new onset CFRD among NHB patients (hazard ratio [HR], 1.40; 95% CI, 1.09-1.80) and a 19% higher risk among Hispanic patients (HR, 1.19; 95% CI, 1.01-1.41; P <.005 for all).
Compared with NHB men, NHB women had increased odds of having CFRD. Other factors associated with higher odds of CFRD included forced expiratory volume in 1 second percent predicted less than 40, liver disease, and public health insurance. Obesity was associated with CFRD incidence in the youngest cohort.
In citing study limitations, the researchers noted that not all eligible patients underwent screening, so CFRD may have been underdiagnosed. Additionally, income data was mostly missing, as was family history of type 2 diabetes.
The study authors concluded, “NHB had higher CFRD prevalence and NHB and Hispanic youth had higher CFRD incidence that were not mitigated after adjusting for genotype. Additionally, public health insurance and obesity associated with CFRD development.”
This article originally appeared on Pulmonology Advisor
References:
Rayas MS, Mbogo B, Kelly A, Vu P, Magaret A, Daley T. Association of race and ethnicity with the development of cystic fibrosis-related diabetes. J Cyst Fibros. Published online August 3, 2024. doi:10.1016/j.jcf.2024.07.018